کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2106546 | 1083524 | 2011 | 5 صفحه PDF | دانلود رایگان |

Venous access is an essential aspect of hemophilia care. When peripheral venipuncture is not feasible, central venous access devices (CVADs) or the creation of an arteriovenous fistula (AVF) allow the infusion of clotting factor concentrate to treat or prevent bleeding events or eliminate inhibitors. Infection is the primary complication associated with CVADs and the most common reason for their removal. Complications of AVF include occlusion and limb length discrepancies.
Research Highlights
► Evaluate the appropriate use, selection, and placement of central venous access devices (CVADs) in patients with hemophilia.
► Examine the roles of education, maintenance, and monitoring in optimizing CVAD use.
► Review CVAD-related complications and strategies for their prevention.
► Evaluate the use of arteriovenous fistulae as an alternative to CVADs when peripheral venipuncture is not feasible.
Journal: Blood Reviews - Volume 25, Issue 1, January 2011, Pages 11–15